New combo therapy targets tough breast cancers in early trial
NCT ID NCT05810870
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug (MEN1611) combined with chemotherapy (eribulin) for people with advanced breast cancer that has specific genetic changes (PIK3CA/PTEN). The goal is to see if the combination can shrink tumors or stop them from growing. About 14 participants will receive the treatment, and researchers will monitor safety and effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHUVI - Complejo Hospitalario Universitario de Vigo
Vigo, Pontevedra, 36312, Spain
-
Centro Oncológico de Galicia
A Coruña, Galicia, 15009, Spain
-
Hospital Beata María Ana
Madrid, Spain
-
Hospital Clínic i Provincial de Barcelona
Barcelona, 08036, Spain
-
Hospital Clínico San Carlos
Madrid, 28040, Spain
-
Hospital Universitari Vall D'Hebron
Barcelona, Spain
-
Hospital Universitario Clínico San Cecilio de Granada
Granada, Andalusia, 18016, Spain
-
Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, 39008, Spain
-
Hospital Universitario Virgen del Rocio
Seville, Andalusia, 41013, Spain
-
Hospital Universitario de Torrejón
Torrejón de Ardoz, Madrid, 28850, Spain
-
Institut Català d' Oncologia L'Hospitalet (ICO)
Barcelona, 08907, Spain
-
Instituto Valenciano de Oncología (IVO)
Valencia, 46009, Spain
-
Onkologikoa
Donostia / San Sebastian, Basque Country, 20014, Spain